Global Indolent Lymphoma Treatment Market Research Report 2019

Table of Contents

Executive Summary

1 Indolent Lymphoma Treatment Market Overview

• 1.1 Product Overview and Scope of Indolent Lymphoma Treatment
• 1.2 Indolent Lymphoma Treatment Segment by Type
  • 1.2.1 Global Indolent Lymphoma Treatment Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 BI-836826
  • 1.2.3 ALT-803
  • 1.2.4 BMS-986016
  • 1.2.5 CC-122
  • 1.2.6 Others
• 1.3 Indolent Lymphoma Treatment Segment by Application
  • 1.3.1 Indolent Lymphoma Treatment Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.3 Global Indolent Lymphoma Treatment Market by Region
  • 1.3.1 Global Indolent Lymphoma Treatment Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Indolent Lymphoma Treatment Market Size
  • 1.4.1 Global Indolent Lymphoma Treatment Revenue (2014-2025)
  • 1.4.2 Global Indolent Lymphoma Treatment Production (2014-2025)

2 Global Indolent Lymphoma Treatment Market Competition by Manufacturers

• 2.1 Global Indolent Lymphoma Treatment Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Indolent Lymphoma Treatment Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Indolent Lymphoma Treatment Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Indolent Lymphoma Treatment Production Sites, Area Served, Product Types
• 2.5 Indolent Lymphoma Treatment Market Competitive Situation and Trends
  • 2.5.1 Indolent Lymphoma Treatment Market Concentration Rate
  • 2.5.2 Indolent Lymphoma Treatment Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Indolent Lymphoma Treatment Production Market Share by Regions

• 3.1 Global Indolent Lymphoma Treatment Production Market Share by Regions
• 3.2 Global Indolent Lymphoma Treatment Revenue Market Share by Regions (2014-2019)
• 3.3 Global Indolent Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Indolent Lymphoma Treatment Production
  • 3.4.1 North America Indolent Lymphoma Treatment Production Growth Rate (2014-2019)
  • 3.4.2 North America Indolent Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Indolent Lymphoma Treatment Production
  • 3.5.1 Europe Indolent Lymphoma Treatment Production Growth Rate (2014-2019)
  • 3.5.2 Europe Indolent Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Indolent Lymphoma Treatment Production (2014-2019)
  • 3.6.1 China Indolent Lymphoma Treatment Production Growth Rate (2014-2019)
  • 3.6.2 China Indolent Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Indolent Lymphoma Treatment Production (2014-2019)
  • 3.7.1 Japan Indolent Lymphoma Treatment Production Growth Rate (2014-2019)
  • 3.7.2 Japan Indolent Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Indolent Lymphoma Treatment Consumption by Regions

• 4.1 Global Indolent Lymphoma Treatment Consumption by Regions
• 4.2 North America Indolent Lymphoma Treatment Consumption (2014-2019)
• 4.3 Europe Indolent Lymphoma Treatment Consumption (2014-2019)
• 4.4 China Indolent Lymphoma Treatment Consumption (2014-2019)
• 4.5 Japan Indolent Lymphoma Treatment Consumption (2014-2019)

5 Global Indolent Lymphoma Treatment Production, Revenue, Price Trend by Type

• 5.1 Global Indolent Lymphoma Treatment Production Market Share by Type (2014-2019)
• 5.2 Global Indolent Lymphoma Treatment Revenue Market Share by Type (2014-2019)
• 5.3 Global Indolent Lymphoma Treatment Price by Type (2014-2019)
• 5.4 Global Indolent Lymphoma Treatment Production Growth by Type (2014-2019)

6 Global Indolent Lymphoma Treatment Market Analysis by Applications

• 6.1 Global Indolent Lymphoma Treatment Consumption Market Share by Application (2014-2019)
• 6.2 Global Indolent Lymphoma Treatment Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Indolent Lymphoma Treatment Business

• 7.1 Altor BioScience Corporation
  • 7.1.1 Altor BioScience Corporation Indolent Lymphoma Treatment Production Sites and Area Served
  • 7.1.2 Indolent Lymphoma Treatment Product Introduction, Application and Specification
  • 7.1.3 Altor BioScience Corporation Indolent Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Amgen Inc.
  • 7.2.1 Amgen Inc. Indolent Lymphoma Treatment Production Sites and Area Served
  • 7.2.2 Indolent Lymphoma Treatment Product Introduction, Application and Specification
  • 7.2.3 Amgen Inc. Indolent Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Astellas Pharma Inc.
  • 7.3.1 Astellas Pharma Inc. Indolent Lymphoma Treatment Production Sites and Area Served
  • 7.3.2 Indolent Lymphoma Treatment Product Introduction, Application and Specification
  • 7.3.3 Astellas Pharma Inc. Indolent Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Bayer AG
  • 7.4.1 Bayer AG Indolent Lymphoma Treatment Production Sites and Area Served
  • 7.4.2 Indolent Lymphoma Treatment Product Introduction, Application and Specification
  • 7.4.3 Bayer AG Indolent Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Boehringer Ingelheim GmbH
  • 7.5.1 Boehringer Ingelheim GmbH Indolent Lymphoma Treatment Production Sites and Area Served
  • 7.5.2 Indolent Lymphoma Treatment Product Introduction, Application and Specification
  • 7.5.3 Boehringer Ingelheim GmbH Indolent Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Bristol-Myers Squibb Company
  • 7.6.1 Bristol-Myers Squibb Company Indolent Lymphoma Treatment Production Sites and Area Served
  • 7.6.2 Indolent Lymphoma Treatment Product Introduction, Application and Specification
  • 7.6.3 Bristol-Myers Squibb Company Indolent Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Celgene Corporation
  • 7.7.1 Celgene Corporation Indolent Lymphoma Treatment Production Sites and Area Served
  • 7.7.2 Indolent Lymphoma Treatment Product Introduction, Application and Specification
  • 7.7.3 Celgene Corporation Indolent Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Eli Lilly and Company
  • 7.8.1 Eli Lilly and Company Indolent Lymphoma Treatment Production Sites and Area Served
  • 7.8.2 Indolent Lymphoma Treatment Product Introduction, Application and Specification
  • 7.8.3 Eli Lilly and Company Indolent Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 F. Hoffmann-La Roche Ltd.
  • 7.9.1 F. Hoffmann-La Roche Ltd. Indolent Lymphoma Treatment Production Sites and Area Served
  • 7.9.2 Indolent Lymphoma Treatment Product Introduction, Application and Specification
  • 7.9.3 F. Hoffmann-La Roche Ltd. Indolent Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Gilead Sciences, Inc.
  • 7.10.1 Gilead Sciences, Inc. Indolent Lymphoma Treatment Production Sites and Area Served
  • 7.10.2 Indolent Lymphoma Treatment Product Introduction, Application and Specification
  • 7.10.3 Gilead Sciences, Inc. Indolent Lymphoma Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Incyte Corporation
• 7.12 Infinity Pharmaceuticals, Inc.
• 7.13 Juno Therapeutics Inc.
• 7.14 MedImmune, LLC

8 Indolent Lymphoma Treatment Manufacturing Cost Analysis

• 8.1 Indolent Lymphoma Treatment Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Indolent Lymphoma Treatment
• 8.4 Indolent Lymphoma Treatment Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Indolent Lymphoma Treatment Distributors List
• 9.3 Indolent Lymphoma Treatment Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Indolent Lymphoma Treatment Market Forecast

• 11.1 Global Indolent Lymphoma Treatment Production, Revenue Forecast
  • 11.1.1 Global Indolent Lymphoma Treatment Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Indolent Lymphoma Treatment Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Indolent Lymphoma Treatment Price and Trend Forecast (2019-2025)
• 11.2 Global Indolent Lymphoma Treatment Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Indolent Lymphoma Treatment Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Indolent Lymphoma Treatment Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Indolent Lymphoma Treatment Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Indolent Lymphoma Treatment Production, Revenue Forecast (2019-2025)
• 11.3 Global Indolent Lymphoma Treatment Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Indolent Lymphoma Treatment Consumption Forecast (2019-2025)
  • 11.3.2 Europe Indolent Lymphoma Treatment Consumption Forecast (2019-2025)
  • 11.3.3 China Indolent Lymphoma Treatment Consumption Forecast (2019-2025)
  • 11.3.4 Japan Indolent Lymphoma Treatment Consumption Forecast (2019-2025)
• 11.4 Global Indolent Lymphoma Treatment Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Indolent Lymphoma Treatment Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List